CRISPR Therapeutics AG (CRSP)
46.30
-0.96
(-2.03%)
USD |
NASDAQ |
Nov 21, 16:00
46.25
-0.05
(-0.11%)
After-Hours: 19:56
CRISPR Therapeutics Market Cap: 3.952B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.034B |
| November 19, 2024 | 4.009B |
| November 18, 2024 | 4.037B |
| November 15, 2024 | 4.033B |
| November 14, 2024 | 3.999B |
| November 13, 2024 | 4.250B |
| November 12, 2024 | 4.330B |
| November 11, 2024 | 4.682B |
| November 08, 2024 | 4.406B |
| November 07, 2024 | 4.428B |
| November 06, 2024 | 4.329B |
| November 05, 2024 | 4.298B |
| November 04, 2024 | 4.318B |
| November 01, 2024 | 4.333B |
| October 31, 2024 | 3.959B |
| October 30, 2024 | 4.090B |
| October 29, 2024 | 4.176B |
| October 28, 2024 | 4.242B |
| October 25, 2024 | 4.042B |
| October 24, 2024 | 4.092B |
| October 23, 2024 | 3.925B |
| October 22, 2024 | 4.100B |
| October 21, 2024 | 4.140B |
| October 18, 2024 | 4.175B |
| October 17, 2024 | 4.121B |
| Date | Value |
|---|---|
| October 16, 2024 | 4.181B |
| October 15, 2024 | 4.100B |
| October 14, 2024 | 4.081B |
| October 11, 2024 | 3.998B |
| October 10, 2024 | 3.873B |
| October 09, 2024 | 3.874B |
| October 08, 2024 | 3.857B |
| October 07, 2024 | 3.882B |
| October 04, 2024 | 3.872B |
| October 03, 2024 | 3.832B |
| October 02, 2024 | 3.901B |
| October 01, 2024 | 3.890B |
| September 30, 2024 | 4.009B |
| September 27, 2024 | 4.030B |
| September 26, 2024 | 3.959B |
| September 25, 2024 | 3.911B |
| September 24, 2024 | 3.985B |
| September 23, 2024 | 3.981B |
| September 20, 2024 | 4.103B |
| September 19, 2024 | 4.215B |
| September 18, 2024 | 4.223B |
| September 17, 2024 | 4.247B |
| September 16, 2024 | 4.066B |
| September 13, 2024 | 4.168B |
| September 12, 2024 | 3.908B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.051B
Minimum
Mar 16 2020
15.53B
Maximum
Jan 14 2021
5.665B
Average
4.878B
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 115.99B |
| AC Immune SA | 325.03M |
| Addex Therapeutics Ltd | 8.795M |
| NLS Pharmaceutics Ltd | 12.93M |
| Molecular Partners AG | 196.71M |
Market Cap Related Metrics
| Price to Book Value | 2.037 |
| Price | 46.30 |
| Earnings Yield | -6.05% |